MARSHALL WACE, LLP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,538,197
+100.9%
183,337
+137.8%
0.00%
+50.0%
Q1 2023$765,652
-65.9%
77,105
-76.1%
0.00%
-60.0%
Q4 2022$2,245,165
+110.0%
322,581
+61.2%
0.01%
+150.0%
Q3 2022$1,069,000
+246.0%
200,163
+157.7%
0.00%
+100.0%
Q2 2022$309,000
-29.5%
77,681
+145.3%
0.00%
-50.0%
Q3 2018$438,00031,6700.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders